Links Site Map
 

To effectively translate state concerns regarding HIV/AIDS and hepatitis care, treatment and prevention programs into sound federal policy, NASTAD applies a multi-layered strategy of communication with executive and legislative branches of the federal and state governments. NASTAD staff members work directly with Members of Congress and their staffs to develop legislative strategies pertaining to both annual appropriations and authorization legislation. NASTAD also plays a key role in shaping AIDS policy through work as a member of the Federal AIDS Policy Partnership (FAPP) and its affiliated work groups such as the HIV Medicare and Medicaid Work Group, the AIDS Budget and Appropriations Coalition and the HIV Prevention Action Committee. NASTAD also coordinates the ADAP Coalition and the Hepatitis C Appropriations Partnership.


Program Highlights
NASTAD Prevention Policy Agenda -- November 2007
On November 29, 2007, NASTAD introduced a Prevention Policy Agenda to accompany its newly-released Blueprint, which includes recommendations for federal funding increases and expansion of core HIV/AIDS programs and services at the state and local levels.

 
NASTAD Comments on HHS Strategic Plan
NASTAD's comments provided on, Draft U.S. Department of Health and Human Services Strategic Plan, Fiscal Year 2007-2012, focus on the need for additional direction from HHS on HIV/AIDS in order to turn the tide on new HIV infections and increase access to care and treatment.

 
NASTAD Comments on HHS Strategic Plan on Hepatitis
NASTAD's comments provided to HHS on their Draft U.S. Department of Health and Human Services Strategic Plan, Fiscal Year 2007-2012, focus on the lack of attention paid to viral hepatitis by the Department. 

 
Role of State Health Departments in HIV/AIDS Programs
State public health agencies serve an important role in delivering HIV/AIDS prevention, care and treatment programs. These agencies are entrusted through U.S. law as the “central authorities of the nation’s public health system” and as such, bear the primary public sector responsibility for health.

 
Hepatitis and HIV Co-Infection Fact Sheet
One-third of people living with HIV in the U.S. are co-infected with HCV and the prevalence of HBV infection among HIV-positive individuals is ten times greater than among the general population.  This fact sheet highlights the unique prevention, treatment and management challenges of managing hepatitis B/HIV and hepatitis C/HIV co-infection.

 
Raising the Profile, Raising Your Voice: A Primer on Viral Hepatitis Policymaking and Programs at the Federal Level
This new document serves to educate persons who are dedicated to viral hepatitis prevention and care about the federal policy process and the programs that address viral hepatitis. Released in May 2007 in conjunction with the commemoration of Hepatitis Awareness Month, NASTAD intends for this document to help raise awareness about the viral hepatitis epidemic in the U.S.

 
NASTAD Press Release on CDC's Revised HIV Incidence Estimates
View Attachment

Letter to Dr. Gerberding Regarding Surveillance Funding Concerns
View Attachment

FY2008 Appropriations Update
View Attachment

Early Diagnosis Grant Program Fact Sheet
View Attachment

Community Sign-on Letter on CHAMP Act
View Attachment

Copyright 2000-2007 - National Alliance of State and Territorial AIDS Directors
444 North Capitol Street, NW • Suite 339 • Washington D.C. 20001 • (202) 434-8090 • NASTAD@NASTAD.org